Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-28 @ 2:50 AM
Study NCT ID:
NCT05575167
Status:
RECRUITING
Last Update Posted:
2025-04-27
First Post:
2022-10-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)
Sponsor:
424 General Military Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2027-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-07
First Submit QC Date:
None
Study First Post Date:
2022-10-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-24
Last Update Post Date:
2025-04-27
Last Update Post Date Type:
ACTUAL